Munafa Stock Market Course + Intraday & FNO calls 
GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Glaxosmithkline Pharmaceuticals GLAXO WideScreen charts, DMA,SMA,EMA technical analysis, forecast prediction, by indicators ADX,MACD,RSI,CCI NSE stock exchange
operates under Pharmaceuticals sector
- IntraDay predictions, targets, What to do GLAXO
- Forcast & Targets GLAXO
- GLAXO Experts view
- Tomorrow's Movement GLAXO
- Technical Analysis Reports
- All in One Charts
- All indicators in One Charts
- GLAXO History
- Money flow charts
- Weekly charts
- Monthly charts
- Moving averages charts
- MACD charts
- Force Index charts
- Stochastics charts
- PVM charts
- RSI and MRSI charts
- Renko charts
- Point and Figure charts
Daily price and charts and targets GlaxosmithklinePharmaceuticals
Strong intraday Stock price targets for GlaxosmithklinePharmaceuticals are 2444.5 and 2528.5
| Intraday Target 1 | 2375.33 |
| Intraday Target 2 | 2429.67 |
| Intraday Target 3 | 2459.3333333333 |
| Intraday Target 4 | 2513.67 |
| Intraday Target 5 | 2543.33 |
Daily price and volume Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 06 February 2026 | 2484.00 (1.61%) | 2444.60 | 2405.00 - 2489.00 | 1.1449 times | Thu 05 February 2026 | 2444.60 (1.56%) | 2407.10 | 2370.30 - 2456.50 | 0.7791 times | Wed 04 February 2026 | 2407.10 (-1.16%) | 2406.60 | 2385.10 - 2420.00 | 0.5549 times | Tue 03 February 2026 | 2435.30 (1.17%) | 2465.00 | 2401.80 - 2475.60 | 1.3559 times | Mon 02 February 2026 | 2407.20 (-0.05%) | 2400.20 | 2342.10 - 2426.60 | 1.149 times | Sun 01 February 2026 | 2408.40 (0.28%) | 2421.40 | 2372.20 - 2448.00 | 0.3166 times | Fri 30 January 2026 | 2401.60 (1.48%) | 2359.90 | 2306.30 - 2414.00 | 1.6707 times | Thu 29 January 2026 | 2366.60 (-2.78%) | 2438.20 | 2345.00 - 2438.20 | 1.1202 times | Wed 28 January 2026 | 2434.20 (3.99%) | 2351.00 | 2331.90 - 2442.90 | 1.1964 times | Tue 27 January 2026 | 2340.80 (1.18%) | 2319.00 | 2278.30 - 2356.20 | 0.7123 times | Fri 23 January 2026 | 2313.40 (-2.81%) | 2381.90 | 2307.60 - 2420.00 | 1.3225 times |
Weekly price and charts GlaxosmithklinePharmaceuticals
Strong weekly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2413.05 and 2559.95
| Weekly Target 1 | 2291.47 |
| Weekly Target 2 | 2387.73 |
| Weekly Target 3 | 2438.3666666667 |
| Weekly Target 4 | 2534.63 |
| Weekly Target 5 | 2585.27 |
Weekly price and volumes for Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 06 February 2026 | 2484.00 (3.43%) | 2421.40 | 2342.10 - 2489.00 | 0.8822 times | Fri 30 January 2026 | 2401.60 (3.81%) | 2319.00 | 2278.30 - 2442.90 | 0.7822 times | Fri 23 January 2026 | 2313.40 (-1.36%) | 2345.90 | 2220.30 - 2420.00 | 1.0124 times | Fri 16 January 2026 | 2345.40 (-1.13%) | 2372.00 | 2337.60 - 2417.10 | 0.5537 times | Fri 09 January 2026 | 2372.10 (-4.5%) | 2484.90 | 2350.00 - 2528.00 | 0.9399 times | Fri 02 January 2026 | 2483.80 (0.79%) | 2483.00 | 2362.60 - 2487.70 | 1.903 times | Fri 26 December 2025 | 2464.30 (-2.56%) | 2530.10 | 2459.50 - 2550.10 | 0.452 times | Fri 19 December 2025 | 2529.00 (-2.76%) | 2587.70 | 2506.70 - 2608.90 | 0.8299 times | Fri 12 December 2025 | 2600.80 (2.17%) | 2545.60 | 2491.00 - 2635.00 | 1.2988 times | Fri 05 December 2025 | 2545.60 (-0.93%) | 2551.00 | 2461.10 - 2582.50 | 1.3458 times | Fri 28 November 2025 | 2569.50 (2.87%) | 2497.90 | 2404.20 - 2585.10 | 1.0886 times |
Monthly price and charts GlaxosmithklinePharmaceuticals
Strong monthly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2413.05 and 2559.95
| Monthly Target 1 | 2291.47 |
| Monthly Target 2 | 2387.73 |
| Monthly Target 3 | 2438.3666666667 |
| Monthly Target 4 | 2534.63 |
| Monthly Target 5 | 2585.27 |
Monthly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 06 February 2026 | 2484.00 (3.43%) | 2421.40 | 2342.10 - 2489.00 | 0.1559 times | Fri 30 January 2026 | 2401.60 (-2.91%) | 2476.00 | 2220.30 - 2528.00 | 0.6115 times | Wed 31 December 2025 | 2473.60 (-3.73%) | 2551.00 | 2362.60 - 2635.00 | 0.9993 times | Fri 28 November 2025 | 2569.50 (-1.88%) | 2644.00 | 2404.20 - 2694.00 | 0.8335 times | Fri 31 October 2025 | 2618.60 (-1.55%) | 2659.70 | 2601.00 - 2795.90 | 0.5412 times | Tue 30 September 2025 | 2659.70 (-4.5%) | 2786.00 | 2622.60 - 2883.40 | 0.8622 times | Fri 29 August 2025 | 2785.00 (-11.94%) | 3162.90 | 2560.00 - 3184.30 | 1.1931 times | Thu 31 July 2025 | 3162.60 (-6.66%) | 3388.70 | 3072.50 - 3450.00 | 0.7285 times | Mon 30 June 2025 | 3388.10 (2.71%) | 3298.00 | 3153.90 - 3515.70 | 1.4575 times | Fri 30 May 2025 | 3298.60 (11.27%) | 2935.30 | 2693.90 - 3398.00 | 2.6173 times | Wed 30 April 2025 | 2964.60 (2.92%) | 2872.00 | 2401.00 - 3148.00 | 1.9567 times |
Yearly price and charts GlaxosmithklinePharmaceuticals
Strong yearly Stock price targets for GlaxosmithklinePharmaceuticals GLAXO are 2352.15 and 2659.85
| Yearly Target 1 | 2103.07 |
| Yearly Target 2 | 2293.53 |
| Yearly Target 3 | 2410.7666666667 |
| Yearly Target 4 | 2601.23 |
| Yearly Target 5 | 2718.47 |
Yearly price and volumes Glaxosmithkline Pharmaceuticals
| Date | Closing | Open | Range | Volume | Fri 06 February 2026 | 2484.00 (0.42%) | 2476.00 | 2220.30 - 2528.00 | 0.0976 times | Wed 31 December 2025 | 2473.60 (9.85%) | 2235.00 | 1921.00 - 3515.70 | 2.6869 times | Tue 31 December 2024 | 2251.85 (18.63%) | 1905.90 | 1842.05 - 3088.00 | 2.2843 times | Fri 29 December 2023 | 1898.15 (43.94%) | 1300.00 | 1227.00 - 1959.00 | 1.2698 times | Fri 30 December 2022 | 1318.75 (-24.93%) | 1763.00 | 1295.95 - 1789.90 | 0.7376 times | Fri 31 December 2021 | 1756.65 (8.17%) | 1607.20 | 1376.00 - 1918.75 | 0.9838 times | Thu 31 December 2020 | 1623.95 (0.85%) | 1626.00 | 962.65 - 1807.50 | 1.0979 times | Tue 31 December 2019 | 1610.30 (6.27%) | 1500.35 | 1130.00 - 1737.00 | 0.4697 times | Mon 31 December 2018 | 1515.35 (-39.13%) | 2490.00 | 1251.00 - 3600.00 | 0.2389 times | Fri 29 December 2017 | 2489.30 (-8.81%) | 2725.00 | 2201.20 - 2798.50 | 0.1336 times | Fri 30 December 2016 | 2729.80 (-17.15%) | 3277.00 | 2600.00 - 3872.00 | 0.1339 times |
Indicator Analysis of GlaxosmithklinePharmaceuticals
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears to be in uptrend. And this trend seems to be continuing further.
Price is above an important level of 2414.14 on charts, and as long as price remains above this level, the uptrend of stock might continue.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO made a big move recently. This generally happens when there is a positive sentiment change, or a block deal went through. There is a good chance that this trend might continue in coming days.
Tomorrow's movement Prediction of Glaxosmithkline Pharmaceuticals GLAXO appears strongly Bullish. This stock started moving upwards as soon as it opened. Generally this happens when there is a positive sentiment following the stock, making it attractive. There's a good chance that this upwards movement will continue tomorrow as well.
Munafa value: 90 as on Fri 06 February 2026
This Munafa value indicates that the stock is moving upwards and might continue to move up.
SMA20 is at 2380 and price is deviating by 53 points
Upper Bollinger band is at 2486 and lower is at 2274, while middle bands are at 2327 and 2433
Price is rising
Price is above 20day SMA
Price is in upper range of bands
Price action analysis of GlaxosmithklinePharmaceuticals (GLAXO) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for GlaxosmithklinePharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for GlaxosmithklinePharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
GlaxosmithklinePharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for GlaxosmithklinePharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of GlaxosmithklinePharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2415.77 and GlaxosmithklinePharmaceuticals GLAXO stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the GlaxosmithklinePharmaceuticals GLAXO stock. Volume based technical analysis of GlaxosmithklinePharmaceuticals GLAXO stock is negative.
GlaxosmithklinePharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
DMA SMA EMA moving averages of Glaxosmithkline Pharmaceuticals GLAXO
DMA (daily moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| DMA period | DMA value |
| 5 day DMA | 2435.64 |
| 12 day DMA | 2401.95 |
| 20 day DMA | 2379.13 |
| 35 day DMA | 2420.39 |
| 50 day DMA | 2461.18 |
| 100 day DMA | 2559.27 |
| 150 day DMA | 2691.04 |
| 200 day DMA | 2794.91 |
EMA (exponential moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| EMA period | EMA current | EMA prev | EMA prev2 |
| 5 day EMA | 2441.38 | 2420.07 | 2407.81 |
| 12 day EMA | 2414.13 | 2401.43 | 2393.58 |
| 20 day EMA | 2410.12 | 2402.35 | 2397.9 |
| 35 day EMA | 2429.09 | 2425.86 | 2424.76 |
| 50 day EMA | 2461.39 | 2460.47 | 2461.12 |
SMA (simple moving average) of Glaxosmithkline Pharmaceuticals GLAXO
| SMA period | SMA current | SMA prev | SMA prev2 |
| 5 day SMA | 2435.64 | 2420.52 | 2411.92 |
| 12 day SMA | 2401.95 | 2384.83 | 2370.49 |
| 20 day SMA | 2379.13 | 2374.87 | 2375.63 |
| 35 day SMA | 2420.39 | 2423.2 | 2427.23 |
| 50 day SMA | 2461.18 | 2461.28 | 2462.11 |
| 100 day SMA | 2559.27 | 2562.17 | 2566.36 |
| 150 day SMA | 2691.04 | 2696.44 | 2702.5 |
| 200 day SMA | 2794.91 | 2796.54 | 2798.39 |
Fundamentals, profit and EPS of Glaxosmithkline Pharmaceuticals GLAXO
EPS is 56.39 and PE is: 44.05
Last quarter profit: (September 2025 quarter) 257.49 crores (2.57%)
Debt: 35.71 in crores
Market capitalization: 43709.18
EPS is 56.09 and PE is: 44.29
Last quarter profit: (June 2025 quarter) 205.01 crores (12.44%)
Debt: 9.95 in crores
Market capitalization: 47197.61
Videos related to: GlaxosmithklinePharmaceuticals GLAXO full analysis,charts,indicators,moving averages,SMA,DMA,EMA,ADX,MACD,RSI
Hindi Video What Is Needed To Succeed In Stock Markets
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
